A month ago, we showed you the premium. This is the discount.
In August we published The Biggest Supplement Wins of 2026: Thorne to P&G for $3.8 billion, Grüns to Unilever for a reported $1.2 billion, IM8 pulling $1 billion in growth financing. Three different deals, one pattern. The brands achieving generational outcomes were disproportionately the ones that could prove their products do something.
A fair question at the time: is that pattern real, or are we just reading tea leaves off three good exits?
On September 1, Nestlé answered it from the other direction.
The deal, at a glance
Nestlé announced it will sell its mainstream vitamins, minerals, and supplements business to US private equity firm Yellow Wood Partners for $1 billion, with the transaction expected to close by the first half of 2027 pending regulatory approvals.
What's included: seven brands (Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu), Nestlé's US private-label supplements business, and the dedicated manufacturing, packaging, warehousing, and distribution operations behind them.
What that business earned: $1.2 billion in sales in 2025, per Nestlé's own reporting.
Do the arithmetic once and it stays with you. A billion dollars for a business selling $1.2 billion a year is a price below one times revenue, for household names with the factories included.
What the industry's own analysts called it
Marc Brush, an industry strategist and former editor of the Nutrition Business Journal, was blunt about the multiple in NutraIngredients' coverage: "I'd put this deal in the distressed assets category." The same coverage framed the sale as a market shift away from legacy brands toward premium, higher-growth assets.
For context on how far the market moved: Nestlé acquired The Bountiful Company, the parent of most of these brands, for $5.75 billion in 2021. Five years later, the bulk of that portfolio is leaving for $1 billion.
What Nestlé said it was keeping
Here is the detail that connects this deal to last month's article. Nestlé is not exiting supplements. Per its own announcement, the company is retaining its premium, science-led brands, Solgar and Pure Encapsulations, the practitioner-channel names built on formulation rigor and clinical credibility.
Read that as a portfolio decision by one of the most sophisticated consumer-health operators on earth. Given the choice of what to keep and what to sell, Nestlé kept the brands whose value rests on science and trust, and sold the brands whose value rests on shelf presence and recognition.
In August, acquirers paid a premium for evidence. In September, a seller took a discount to exit everything but the evidence.
What this means if you're building a brand
The takeaway from August still stands, and this deal sharpens it. The question the market keeps asking is not how much revenue you have. Nature's Bounty had plenty. The question is what your revenue rests on, and whether the thing underneath it survives scrutiny.
You do not need a pharma-scale program to start building that foundation. The same ladder we laid out last month applies: match the study type to the claim you want to make, start with your hero product, and treat evidence as an asset you accumulate the way you accumulate customers. If you want to see what the first rung looks like in practice, we wrote about when a pilot study makes sense.
The brands in August's article built the asset and were paid for it. The brands in this month's deal never did, and the price said so.
Ready to start building the evidence behind your product? Schedule a strategy call and we'll map the right study design for your product, timeline, and research goals.
Common questions
What exactly did Nestlé sell?
Seven mainstream vitamin and supplement brands (Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu), plus its US private-label supplements business and the manufacturing, packaging, warehousing, and distribution operations behind them, to Yellow Wood Partners for $1 billion. The deal is expected to close by the first half of 2027, pending regulatory approvals.
What is Nestlé keeping?
Its premium, science-led supplement brands, Solgar and Pure Encapsulations. Nestlé framed the divestiture as a way to concentrate on the parts of the category where it believes it competes best.
How much did Nestlé originally pay for these brands?
Nestlé acquired The Bountiful Company, the parent of most of the divested brands, for $5.75 billion in 2021. The mainstream portfolio is now leaving for $1 billion.